Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$242,151,742
+$66,340,466 QoQ
Shares Held
201,889
+5.6% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#239
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIL Ltd holds $2,310,187,043 across 11 Drug Manufacturers - General names. LLY ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
4,492,612 | $851,889,084 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
6,523,813 | $375,902,104 | |
| 3 | PFE |
Pfizer Inc
|
10,482,713 | $252,423,729 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
201,889 | $242,151,742 | |
| 5 | ABBV |
AbbVie Inc.
|
677,123 | $170,391,231 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
987,104 | $124,710,718 | |
| 7 | JNJ |
Johnson & Johnson
|
431,712 | $109,641,896 | |
| 8 | MRK |
Merck & Co., Inc.
|
678,957 | $87,245,974 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,151,742 | 201,889 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $175,811,276 | 191,147 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $212,271,887 | 197,521 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $59,180,569 | 77,563 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $120,742,960 | 154,892 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $164,285,061 | 198,914 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $134,158,160 | 173,780 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $238,221,291 | 268,891 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $254,161,894 | 280,724 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $179,958,484 | 231,321 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $122,992,622 | 210,994 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $127,528,627 | 237,426 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $112,862,850 | 240,656 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $56,380,978 | 164,175 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $68,899,378 | 188,332 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $60,752,291 | 187,884 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $42,561,672 | 131,270 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $41,054,575 | 143,362 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $68,004,535 | 246,197 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $55,416,418 | 239,846 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $52,898,391 | 230,474 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $48,337,619 | 258,739 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $43,685,491 | 258,739 | Shares | Defined | 2021-03-23 | |
| 2020-09-30 | $28,863 | 195 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $32,014 | 195 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $27,743 | 200 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||